Clinical Trial Update: Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Melphalan-Prednisone versus Melphalan-Prednisone plus Thalidomide in newly diagnosed patients over 75 with multiple myeloma has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Newly Diagnosed, Multiple Myeloma | Phase 3 | Status: TERMINATED